FULC

Fulcrum Therapeutics, Inc.

8.00 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Fulcrum Therapeutics, Inc. stock is up 19.76% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 5 July’s closed higher than June. In the last 7 Unusual Options Trades, there were 5 PUTs, 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
11 Jun 17:34 21 Jun, 2024 7.00 PUT 3532 50
11 Jun 17:36 17 Jan, 2025 11.00 PUT 53 0
11 Jun 17:56 17 Jan, 2025 11.00 PUT 384 0
20 Jun 15:43 21 Jun, 2024 7.00 PUT 1258 5021
12 Jul 18:35 17 Jan, 2025 10.00 CALL 100 13492
16 Jul 15:34 20 Dec, 2024 15.00 CALL 145 115
18 Jul 17:17 20 Dec, 2024 10.00 PUT 500 28

About Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc. focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin.